Lipitor’s Dangers Lead to FDA Safety Advisory
Lipitor is part of a group of cholesterol-lowering drugs called statins. Statins are designed to decrease the “bad” cholesterol and increase the “good” cholesterol in the blood. They are taken by tens of millions of Americans and are overall found to be successful at reducing heart attacks. However, some concerns have been raised about possible […]
Understanding Birth Defect Risks Associated with Depakote
Depakote (valproic acid) is a medication used to treat seizures and other neurological conditions. While the drug can be beneficial to some, it is highly recommended that pregnant women avoid taking the drug at all. Depakote use during pregnancy greatly increases the risk of several types of birth defects, according to several studies performed by […]
FDA Warning: Depakote May Cause Serious Birth Defects
Women who are pregnant or who may become pregnant should consider their treatment options before accepting a prescription for Depakote, a branded version of valporic acid made by Abbott Laboratories in the United States. Studies show that the drug increases the risk of birth defects. It has also been linked to lower IQs in the […]
FDA Issues Additional Warnings to Health Care Providers on GranuFlo Recall
In May 2012, the U.S. Food and Drug Administration (FDA) issued a recall notice for NaturaLyte Liquid Acid Concentrate and GranuFlo (powder) Acid Concentrate. Both products are dialysates, which are used during the dialysis process to clean a kidney patient’s blood and restore electrolyte balance – tasks the kidneys would carry out if they were […]
FDA Investigates Fresenius for Failure to Warn of GranuFlo Risks
The U.S. Food and Drug Administration (FDA) recently launched an investigation into Fresenius Medical Care, the nation’s largest provider of dialysis services to kidney patients. The investigation focuses on whether Fresenius failed to adequately warn doctors and patients of the risk of cardiac arrest and other serious medical conditions linked to the use of two […]
Pradaxa Lawsuits Joined
Pradaxa, an oral anticoagulant developed by the Boehringer Ingelheim pharmaceutical company, was supposed to prevent strokes in patients with atrial fibrillation. Unfortunately, many patients who were prescribed the drug found that it had adverse side effects that neither they, nor their doctors, understood. Internal bleeding stands out as one of the most problematic side effects, […]
Pradaxa Lawsuits Consolidated in Illinois
Yesterday, a panel of Federal Judges ruled that 21 lawsuits against the drug manufacturer Boehringer Ingelheim Pharmaceuticals should be joined together in front of one Federal Judge in the Southern District of Illinois. This consolidation, known as multi-district litigation, is intended to allow cases to move along more quickly and efficiently. The cases that have […]
New Actos Study Again Links the Drug to Bladder Cancer
According to a new study, published in the Canadian Medical Association Journal, patients with type 2 diabetes have a 40% increased risk of developing bladder cancer. Evidence found in the study reveals that those patients who have been taking pioglitazone, which goes by its brand name, Actos, suffer from a greater incidence of the cancer. […]
Study of Cardiovascular Drug Dronedarone Ends Early Due to Severe Risk of Death from Drug
A recent study of the drug dronedarone, which is used to treat patients suffering from intermittent abnormal heart rhythm, had to be stopped early because of a high level of danger for many of the patients taking the drug. The study tested the drugs on patients who suffered from both intermittent and permanent heart arrhythmia, […]
The Dangerous Side Effects of Propoxyphene
Propoxyphene was first approved by the U.S. Food and Drug Administration (FDA) in 1957 as a pain reliever, and has since been used by about 10 million patients. However, the drug was recently pulled off the market, according to MedScape.com. Five years ago, the drug was banned in the United Kingdom because it posed a […]